Filter
83
Filtered Results: 83
Text search:
Brozek,
J.
L.
Featured
Recommendations
17
New Publications
21
Language
Document type
Guidelines
37
No document type
31
Studies & Reports
11
Manuals
2
Training Material
1
Fact sheets
1
Countries / Regions
Brazil
5
Russia
5
Global
4
Latin America and the Carribbean
3
South Africa
3
Peru
2
Malawi
2
Mozambique
2
Guinea-Bissau
2
Angola
2
Nepal
1
Rwanda
1
Estonia
1
Germany
1
Eastern Europe and Central Asia
1
Western and Central Europe
1
North America
1
Uganda
1
Eastern Europe
1
Romania
1
Ethiopia
1
Authors & Publishers
Publication Years
Category
Gynaecology & Obstetrics
10
COVID-19
9
Maternal Health
8
Studies & Reports
7
Guidelines
6
Non-communicable Diseases
4
TB
4
Drugs & Medical Equipment
3
Women & Child Health
3
Capacity Building
3
Reproductive Health
3
Paediatrics
2
Bacteriology
2
Pediatrics
2
Policies & Guidelines HIV & TB
2
Community Health
2
Hepatitis
1
Under-5 nutrition
1
Diabetes
1
Community Health
1
Infection Control & Prevention (IPC)
1
Chagas
1
NCD
1
Cardiovascular Diseases
1
WASH
1
Respiratory Infections
1
Quality Control & Assurance
1
Surgery & Anaesthesia
1
General Guidelines
1
Leprosy
1
Primary Health Care
1
HIV & STI
1
Disease Prevention & Control
1
Toolboxes
Clinical Guidelines
10
Detection & Diagnosis
7
Midwives
5
Country specific documents
4
Prevention & Strategies
4
Drug resistant TB
4
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
2
Children/Adolescents Mental Disorders
2
Treatment Guidelines
2
Essential Medicines & Medical Devices
2
Essential Medicines & Devices Lists
2
Women & Maternal Health
2
Women
2
War & Conflict
1
Psychosocial Support (MHPSS)
1
HIV testing & services
1
Clinical Guidelines
1
IPC
1
Prevention & Control
1
Adults
1
Policies & Programmes
1
Training Manuals
1
Influenza
1
Clinical Guidelines
1
General Studies & Reports
1
Studies & Reports
1
Physiotherapy & Rehabilitation
1
Essential List
1
Diagnostics & Laboratory Guidance
1
Clinical Guidelines
1
Medical & Community Masks
1
Hygiene
1
Studies & Reports
1
Estonia
1
Antimicrobial Resistance (AMR)
1
Nuclear & Chemical Hazards
1
Capacity Building & Resources
1
Clinical Aspects & Diagnostics
1
Studies & Reports
1
Global Overview
1
Diagnosis
1
Romania
1
Cerebral Palsy
1
Training
1
Germany
1
Assessment
1
Depression
1
Treatment & Clinical Management
1
These WHO guidelines which were updated in 2018, are valid for any country and suitable to local adaptations, and take account of the strength of available scientific evidence, the cost and resource implications, and patient values and preferences.
The 2018 edition of the guidelines includes the re...
Updated 17 April 2020
Improving care for women during pregnancy and around the time of childbirth to prevent and treat pre-eclampsia and eclampsia is a necessary step towards the achievement of the health targets of the Sustainable Development Goals (SDGs). Efforts to prevent and reduce morbidity a...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
This document updates the 2014 Core Elements for Hospital Antibiotic Stewardship Programs and incorporates new evidence and lessons learned from experience with the Core Elements. The Core Elements are applicable in all hospitals, regardless of size. There are suggestions specific to small and criti...
Настоящее руководство «Клиническое ведение случаев COVID-19» базируется на
вышеуказанных стратегических приоритетах и адресовано клиницистам, участвующим в
оказа...
WHO estimates that in 2015, 257 million people were living with chronic hepatitis B virus (HBV) infection worldwide, and that 900 000 died from HBV infection, mostly through the development of cirrhosis and hepatocellular carcinoma. Worldwide, the majority of persons with chronic hepatitis B infecti...
Guidance statement
Recommendations on contraceptive methods used by
women at high risk of HIV
Вариативные рекомендации 24 сентября 2021 г.
Этот документ представляет собой текущие рекомендации ВОЗ. В них будут вноситься изменения и дополнения,
касающиеся нов...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
6 July 2021. The “WHO consolidated guidelines on tuberculosis. Module 3: Diagnosis - Rapid diagnostics for tuberculosis detection 2021 update” is the latest document replacing the one issued in 2020. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included in the...
3 March 2022
The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an ...
La presente publicación describe un resumen de la evidencia científica disponible sobre el uso de Cloroquina e hidroxicloroquina, así como su profilaxis y tratamiento para COVID-19.
Esta publicación pertenece al compendio Publicaciones Minsa sobre COVID-19
La presente publicación describe la evidencia científica disponible sobre la precisión diagnóstica de las pruebas rápidas de detección de antígenos para SARS-COV-2. El conocimiento de las pruebas diagnósticas para el coronavirus del síndrome respiratorio agudo grave 2 (SARS-COV-2) sigue evo...
Esta primeira versão de Medicamentos para prevenção da COVID-19: Orientação dinâmica da OMS aborda o uso de hidroxicloroquina para prevenção da COVID-19. Segue-se a publicação de uma análise sistemática e NMA que reuniu dados de seis estudos com 6.059 participantes que não tinham COVID-...
Resumo: o que é esta orientação dinâmica?
Pergunta clínica: qual é o papel dos medicamentos na prevenção da COVID-19?
Público-alvo: o público-alvo são os médicos e os tomadores de decisão na área da saúde.
Prática atual: o uso atual de medicamentos para prevenção da COVID-19 é ...
List of essential medicines for the management of patients admitted in intensive care units with a suspected or confirmed diagnosis of COVID 19. Third version, 1 February 2022
Therapeutics for Ebola virus disease
recommended
The WHO Ebola Virus Disease (EVD) Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with EVD. Providing guidance that is comprehensive and holistic for the optimal care of patients with EVD throughout their il...
